Venter says gene testing results show discrepancies

10/7/2009 | Bloomberg

Genetic testing firms such as Navigenics and 23andMe don't always agree when predicting an individual's risk for diseases based on the genetic makeup because they use different markers when making such predictions, genome pioneer J. Craig Venter and colleagues said in an opinion article in Nature. Companies could generate compatible genetic results by agreeing on a core set of markers, Venter said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health